LDX announced yesterday FDA approval for a bacterial test. Just because of "FDA approval" the MC rose from $3m to about $40m.
Let's hope the market will react in a similar way when CHM gets its FDA approvals one day. CHM's tech save lives, not sure if LDX' test has that capability.
GLTA
Ann: CHM secures up to A$12.6m through SPP and placements, page-18
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable